Strong instrumental variables biased propensity scores in comparative effectiveness research: a case study in oncology
CONCLUSION: In setting of highly predictive pre-treatment procedures, excluding the immediate pre-exposure time from the CAP will reduce the risk of including potential IVs in PS models and may reduce bias.PMID:36657590 | DOI:10.1016/j.jclinepi.2023.01.002
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Nicolas H Thurin J érémy Jové R égis Lassalle Magali Rouyer St éphanie Lamarque Pauline Bosco-Levy Corentin Segalas Sebastian Schneeweiss Patrick Blin C écile Droz-Perroteau Source Type: research
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Databases & Libraries | Docetaxel | Epidemiology | France Health | Prostate Cancer | Study | Taxotere